Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 31 to 40 of 86

TitleReference numberPublishedLast updated
Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiationTA798
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterationsTA789
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesHTG611
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancerTA770
Microwave ablation for primary or metastatic cancer in the lungHTG609
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancerTA724
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapyTA713
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancerTA705
Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancerTA683

Results per page

  1. 10
  2. 25
  3. 50
  4. All